{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:25:33Z","timestamp":1780352733048,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.iccl.2024.11.010","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:24:18Z","timestamp":1737552258000},"page":"243-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Femoropopliteal Interventions for Peripheral Artery Disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Adam P.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha D.","family":"Minc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Antonio","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.iccl.2024.11.010_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2024.11.010_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.iccl.2024.11.010_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMcp064483","article-title":"Clinical practice. Intermittent claudication","volume":"356","author":"White","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iccl.2024.11.010_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.avsg.2021.04.037","article-title":"Peripheral artery disease leading to major amputation: trends in revascularization and mortality over 18 years","volume":"78","author":"Abry","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.10765","article-title":"Risk of major amputation in patients with intermittent claudication undergoing early revascularization","volume":"105","author":"Golledge","year":"2018","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jvs.2021.02.045","article-title":"Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates","volume":"74","author":"Madabhushi","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: Revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"issue":"24","key":"10.1016\/j.iccl.2024.11.010_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001251","article-title":"ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jvs.2023.03.029","article-title":"Carbon dioxide angiography during peripheral vascular interventions is associated with decreased cardiac and renal complications in patients with chronic kidney disease","volume":"78","author":"Lee","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib11","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.4390","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","author":"Kaplovitch","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"20","key":"10.1016\/j.iccl.2024.11.010_bib13","article-title":"Underutilization of evidence-based smoking cessation support strategies despite high smoking addiction burden in peripheral artery disease specialty care: insights from the international PORTRAIT registry","volume":"7","author":"Patel","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamacardio.2021.3979","article-title":"Association of smoking with postprocedural complications following open and endovascular interventions for intermittent claudication","volume":"7","author":"Reitz","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.iccl.2024.11.010_bib15","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"ACC expert consensus decision pathway on tobacco cessation treatment","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.iccl.2024.11.010_bib16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamacardio.2021.3987","article-title":"Smoking cessation improves outcomes in patients with peripheral artery disease","volume":"7","author":"Creager","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib18","article-title":"Cilostazol for intermittent claudication","volume":"2021","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.010_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","article-title":"Supervised walking therapy in patients with intermittent claudication","volume":"56","author":"Fakhry","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.010_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib21","article-title":"Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Vascular Group","volume":"2018","author":"Fakhry","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.iccl.2024.11.010_bib22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","article-title":"Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication","volume":"10","author":"Pandey","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib23","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1016\/j.jvs.2014.12.007","article-title":"A\u00a0systematic review of treatment of intermittent claudication in the lower extremities","volume":"61","author":"Malgor","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jvs.2019.08.278","article-title":"Patients undergoing interventions for claudication experience low perioperative morbidity but are at risk for worsening functional status and limb loss","volume":"72","author":"Levin","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jvs.2017.12.044","article-title":"Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival","volume":"68","author":"Jones","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"issue":"18","key":"10.1016\/j.iccl.2024.11.010_bib26","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2015.15116","article-title":"Erasing disability in peripheral artery disease: the role of endovascular procedures and supervised exercise","volume":"314","author":"McDermott","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2024.11.010_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/VHRM.S242291","article-title":"An overview of the treatment of symptomatic common femoral artery lesions with a focus on endovascular therapy","volume":"16","author":"Shammas","year":"2020","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.iccl.2024.11.010_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.RVI.0000220367.62137.E8","article-title":"In\u00a0Vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion","volume":"17","author":"Cheng","year":"2006","journal-title":"J\u00a0Vasc Intervent Radiol"},{"issue":"5 SUPPL","key":"10.1016\/j.iccl.2024.11.010_bib30","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus angioplasty in severe ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.010_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/medicina58091293","article-title":"Algorithm of femoropopliteal endovascular treatment","volume":"58","author":"Dubosq","year":"2022","journal-title":"Medicina (Mex)"},{"key":"10.1016\/j.iccl.2024.11.010_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.avsg.2021.06.012","article-title":"Antegrade superficial femoral artery approach using manual compression and 4-f delivery system for infrainguinal occlusive disease","volume":"78","author":"Nasr","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.010_bib33","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jvs.2021.04.050","article-title":"A\u00a0systematic review of the ipsilateral retrograde approach to the treatment of femoropopliteal arterial lesions","volume":"74","author":"Martin","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"issue":"2","key":"10.1016\/j.iccl.2024.11.010_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejvs.2020.11.020","article-title":"Technical success and complication rates of retrograde arterial access for endovascular therapy for critical limb ischaemia: a systematic review and meta-analysis","volume":"61","author":"Giannopoulos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.iccl.2024.11.010_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jvs.2021.09.022","article-title":"Technical perspectives in the management of complex infrainguinal arterial chronic total occlusions","volume":"75","author":"Solimeno","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.010_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/HCV.0000000000000035","article-title":"An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association","volume":"11","author":"Mason","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.010_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jvs.2020.02.016","article-title":"Safety and feasibility of transradial infrainguinal peripheral arterial disease interventions","volume":"72","author":"Sher","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"issue":"9501","key":"10.1016\/j.iccl.2024.11.010_bib38","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Bradbury","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2024.11.010_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.avsg.2023.11.024","article-title":"Robustness of longitudinal safety and efficacy after paclitaxel-based endovascular therapy for treatment of femoro-popliteal artery occlusive disease: an updated systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"D\u2019Oria","year":"2024","journal-title":"Ann Vasc Surg"},{"issue":"11","key":"10.1016\/j.iccl.2024.11.010_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2024.11.010_bib41","article-title":"Systematic review and meta-analysis of clinical outcomes after endovascular treatment in patients with femoropopliteal lesions greater than 150 mm","author":"Dubosq-Lebaz","year":"2023","journal-title":"J\u00a0Endovasc Ther"},{"issue":"27","key":"10.1016\/j.iccl.2024.11.010_bib42","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","article-title":"COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions","volume":"41","author":"Steiner","year":"2020","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.iccl.2024.11.010_bib43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2022.06.043","article-title":"Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention","volume":"80","author":"Krishnan","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ccd.27635","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Cathet Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.iccl.2024.11.010_bib45","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10415","key":"10.1016\/j.iccl.2024.11.010_bib46","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.010_bib47","article-title":"Survival and causes of death among veterans with lower extremity revascularization with paclitaxel-coated devices: insights from the veterans health administration","volume":"10","author":"Gutierrez","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"26","key":"10.1016\/j.iccl.2024.11.010_bib48","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2024.11.010_bib49","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among medicare beneficiaries: the SAFE-PAD Study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"18","key":"10.1016\/j.iccl.2024.11.010_bib50","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2021.08.052","article-title":"Safety and effectiveness of paclitaxel drug-coated devices in peripheral artery revascularization","volume":"78","author":"Hess","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.iccl.2024.11.010_bib51","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.iccl.2024.11.010_bib52","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.iccl.2024.11.010_bib53","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2024.11.010_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004450","article-title":"Impact of fluoropolymer-based paclitaxel delivery on neointimal proliferation and vascular healing: a comparative peripheral drug-eluting stent study in the familial hypercholesterolemic swine model of femoral restenosis","volume":"10","author":"Gasior","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.iccl.2024.11.010_bib56","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the imperial randomized study of the eluvia polymer-coated drug-eluting stent and the zilver PTX Polymer-free Drug-Coated Stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"16","key":"10.1016\/j.iccl.2024.11.010_bib58","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-month results of the Lutonix global SFA registry","volume":"10","author":"Thieme","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.010_bib59","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jcin.2024.03.015","article-title":"Randomized trial comparing a stent-avoiding with a stent-preferred strategy in complex femoropopliteal lesions","volume":"17","author":"Wittig","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.11.010_bib60","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.avsg.2022.03.031","article-title":"A\u00a0systematic review aggregated data and individual participant data meta-analysis of spot stenting in the treatment of lower extremity peripheral arterial disease","volume":"85","author":"Bontinis","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"10.1016\/j.iccl.2024.11.010_bib61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib62","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.jvs.2018.03.417","article-title":"Peripheral atherectomy practice patterns in the United States from the vascular quality initiative","volume":"68","author":"Mohan","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.010_bib63","article-title":"Atherectomy for peripheral arterial disease. Cochrane Vascular Group","volume":"2020","author":"Wardle","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejvs.2021.02.012","article-title":"Atherectomy combined with balloon angioplasty versus balloon angioplasty alone for de novo femoropopliteal arterial diseases: a systematic review and meta-analysis of randomised controlled trials","volume":"62","author":"Wu","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/15266028231215354","article-title":"Efficacy and safety of atherectomy combined with balloon angioplasty vs balloon angioplasty alone in patients with femoro-popliteal lesions: a systematic review and meta-analysis of randomized controlled trials","author":"Pan","year":"2023","journal-title":"J\u00a0Endovasc Ther"},{"issue":"2","key":"10.1016\/j.iccl.2024.11.010_bib66","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jvs.2021.07.106","article-title":"Critical appraisal of the contemporary use of atherectomy to treat femoropopliteal atherosclerotic disease","volume":"75","author":"Gupta","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/15266028241255622","article-title":"Intravascular lithotripsy for treatment of severely calcified common femoral artery disease: results from the disrupt PAD III observational study","author":"Shammas","year":"2024","journal-title":"J\u00a0Endovasc Ther"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.010_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/15266028221075563","article-title":"Intravascular lithotripsy and drug-coated balloon angioplasty for severely calcified femoropopliteal arterial disease","volume":"30","author":"Stavroulakis","year":"2023","journal-title":"J\u00a0Endovasc Ther"},{"issue":"12","key":"10.1016\/j.iccl.2024.11.010_bib69","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.010_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ejvs.2021.10.035","article-title":"Efficacy and safety of intravascular lithotripsy in lower extremity peripheral artery disease: a systematic review and meta-analysis","volume":"63","author":"Wong","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"10.1016\/j.iccl.2024.11.010_bib71","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcin.2022.01.001","article-title":"The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions","volume":"15","author":"Allan","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.iccl.2024.11.010_bib72","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jcin.2022.04.034","article-title":"Appropriate use of intravascular ultrasound during arterial and venous lower extremity interventions","volume":"15","author":"Secemsky","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.11.010_bib73","first-page":"13","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","author":"Farber","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2024.11.010_bib74","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.iccl.2024.11.010_bib75","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2024.11.010_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.avsg.2019.01.014","article-title":"Demystifying the use of self-expandable interwoven nitinol stents in femoropopliteal peripheral arterial disease","volume":"59","author":"Peker","year":"2019","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib77","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jvs.2019.08.284","article-title":"A\u00a0midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents","volume":"71","author":"Chan","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.avsg.2018.09.024","article-title":"Comparison of clinical outcomes between endovascular therapy with self-expandable nitinol stent and femoral\u2013popliteal bypass for trans-atlantic inter-society consensus II C and D femoropopliteal lesions","volume":"57","author":"Okuno","year":"2019","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejvs.2019.09.002","article-title":"Comparison between interwoven nitinol and drug eluting stents for endovascular treatment of femoropopliteal artery disease","volume":"58","author":"Haine","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib80","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","author":"Varcoe","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.010_bib81","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jvs.2024.02.004","article-title":"DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease","volume":"79","author":"Lyden","year":"2024","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.iccl.2024.11.010_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100250","article-title":"Improving the enrollment of women and racially\/ethnically diverse populations in cardiovascular clinical trials: an ASPC practice statement","volume":"8","author":"Michos","year":"2021","journal-title":"Am J Prev Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:08:55Z","timestamp":1750180135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2211745824001287"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.11.010","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Femoropopliteal Interventions for Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}